Literature DB >> 18465318

Improvement of prognosis in breast cancer in Denmark 1977-2006, based on the nationwide reporting to the DBCG Registry.

Henning T Mouridsen1, Karsten D Bjerre, Peer Christiansen, Maj-Britt Jensen, Susanne Møller.   

Abstract

INTRODUCTION: Since 30 years DBCG (Danish Breast Cancer Coperative Group) has maintained, on a nation-wide basis, a clinical database of diagnostic procedures, therapeutic interventions, and clinical outcome in patients with primary breast cancer. The present analysis was undertaken to evaluate the development of the prognosis since 1977, and to analyse factors potentially contributing to the change of the prognosis.
MATERIAL AND METHODS: All cases of invasive breast cancer reported to DBCG during the period 1977-2006 were included in the present analysis.
RESULTS: A total of close to 80 000 patients were registered in the DBCG Database. Since 1977 the prognosis has improved significantly, thus 5 year survival for the total population of patients with primary breast cancer has increased from 65 to 81%. DISCUSSION: According to the present analysis diagnosis at an earlier stage in the natural course of the disease and especially the development of more active systemic treatment modalities have contributed to the improved prognosis.

Entities:  

Mesh:

Year:  2008        PMID: 18465318     DOI: 10.1080/02841860802027009

Source DB:  PubMed          Journal:  Acta Oncol        ISSN: 0284-186X            Impact factor:   4.089


  7 in total

1.  Acquisition of docetaxel resistance in breast cancer cells reveals upregulation of ABCB1 expression as a key mediator of resistance accompanied by discrete upregulation of other specific genes and pathways.

Authors:  Stine Ninel Hansen; David Westergaard; Mathilde Borg Houlberg Thomsen; Mette Vistesen; Khoa Nguyen Do; Louise Fogh; Kirstine C Belling; Jun Wang; Huanming Yang; Ramneek Gupta; Henrik J Ditzel; José Moreira; Nils Brünner; Jan Stenvang; Anne-Sofie Schrohl
Journal:  Tumour Biol       Date:  2015-01-18

2.  Pre- and post-operative psychological interventions to prevent pain and fatigue after breast cancer surgery (PREVENT): Protocol for a randomized controlled trial.

Authors:  Silje Endresen Reme; Alice Munk; Marianne Therese Smogeli Holter; Ragnhild S Falk; Henrik Børsting Jacobsen
Journal:  PLoS One       Date:  2022-07-08       Impact factor: 3.752

3.  Survival of women with breast cancer in central and northern Denmark, 1998-2009.

Authors:  Lone Winther Lietzen; Gitte Vrelits Sørensen; Anne Gulbech Ording; Jens Peter Garne; Peer Christiansen; Mette Nørgaard; Jacob Jacobsen
Journal:  Clin Epidemiol       Date:  2011-07-21       Impact factor: 4.790

4.  Association of miR-548c-5p, miR-7-5p, miR-210-3p, miR-128-3p with recurrence in systemically untreated breast cancer.

Authors:  Ines Block; Mark Burton; Kristina P Sørensen; Lars Andersen; Martin J Larsen; Martin Bak; Søren Cold; Mads Thomassen; Qihua Tan; Torben A Kruse
Journal:  Oncotarget       Date:  2018-01-09

5.  De novo and recurrent metastatic breast cancer - A systematic review of population-level changes in survival since 1995.

Authors:  S J Lord; K Bahlmann; D L O'Connell; B E Kiely; B Daniels; S A Pearson; J Beith; M K Bulsara; N Houssami
Journal:  EClinicalMedicine       Date:  2022-01-29

6.  Long-term effects of complex decongestive therapy in breast cancer patients with arm lymphedema after axillary dissection.

Authors:  Jung Min Hwang; Ji Hye Hwang; Tae Won Kim; Seung Yeol Lee; Hyun Ju Chang; In Ho Chu
Journal:  Ann Rehabil Med       Date:  2013-10-29

Review 7.  Danish Breast Cancer Cooperative Group.

Authors:  Peer Christiansen; Bent Ejlertsen; Maj-Britt Jensen; Henning Mouridsen
Journal:  Clin Epidemiol       Date:  2016-10-25       Impact factor: 4.790

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.